Journals / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 2

Effects of Topical Coenzyme Q10 on Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with OpenAngle Glaucoma

Pages
190–194
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The combination of CQ10 and Vit E treatment can have beneficial effects on the RNFL in primary OAG patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Recent studies have shown that retinal ganglion cell apoptosis is of great importance in the pathophysiology of glaucoma.
📊
Key Findings & Data:Coenzyme Q10 (CQ10) is a molecule used for its neuroprotective effect in the treatment of glaucoma.
💡
Conclusion & Impact:The combination of CQ10 and Vit E treatment can have beneficial effects on the RNFL in primary OAG patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Recent studies have shown that retinal ganglion cell apoptosis is of great importance in the pathophysiology of glaucoma. Coenzyme Q10 (CQ10) is a molecule used for its neuroprotective effect in the treatment of glaucoma. Our aim was to evaluate the effect of CQ10 and Vitamin E (Vit E) combination on retinal nerve fiber layer (RNFL) and ganglion cell complex in open-angle glaucoma (OAG) patients by optical coherence tomography (OCT). Methods: In this retrospective study, thirty-one OAG patients with glaucoma in both eyes (intraocular pressure [IOP] 0.05) at baseline. There was a significant increase in the average RNFL value at baseline and after 6 months of treatment in the GC group (p=0.045). In the GC group, the differences in the superior RNFL and the average RNFL values after 6 months were significantly greater than those recorded in the GT group (p=0.019, p=0.034, respectively). Discussion and Conclusion: In our study, we found a statistically significant effect of CQ10 on the RNFL. The combination of CQ10 and Vit E treatment can have beneficial effects on the RNFL in primary OAG patients.

🔖

Cite This Article

VURAL, E. T., ALPOĞLAN, O., TOKLU, M., ERSANLI, A., BULUT, M. N., İMAMOĞLU, S. (2022). Effects of Topical Coenzyme Q10 on Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with OpenAngle Glaucoma. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 2, 190–194. https://ajindex.com/articles/535849

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262–7
  2. Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet 2017;390:2183–93
  3. Osborne NN. Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma. Exp Eye Res 2010;90:750–7
  4. Zhou RR, Li HB, You QS, Rong R, You ML, Xiong K, et al. Silencing of GAS5 alleviates glaucoma in rat models by reducing retinal ganglion cell apoptosis. Hum Gene Ther 2019;30:1505–19
  5. Manzar H, Abdulhussein D, Yap TE, Cordeiro MF. Cellular consequences of coenzyme Q10 deficiency in neurodegeneration of the retina and Brain. Int J Mol Sci 2020;21:9299
  6. Nakajima Y, Inokuchi Y, Nishi M, Shimazawa M, Otsubo K, Hara H. Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res 2008;1226:226–33
  7. Ju WK, Shim MS, Kim KY, Bu JH, Park TL, Ahn S, et al. Ubiquinol promotes retinal ganglion cell survival and blocks the apoptotic pathway in ischemic retinal degeneration. Biochem Biophys Res Commun 2018;503:2639– 45
  8. Davis BM, Tian K, Pahlitzsch M, Brenton J, Ravindran N, Butt G, et al. Topical coenzyme Q10 demonstrates mitochondrialmediated neuroprotection in a rodent model of ocular hypertension. Mitochondrion 2017;36:114–23
  9. Nucci C, Tartaglione R, Cerulli A, Mancino R, Spanò A, Cavaliere F, et al. Retinal damage caused by high intraocular pressureinduced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol 2007;82:397–406
  10. Tatham AJ, Medeiros FA. Detecting structural progression in glaucoma with optical coherence tomography. Ophthalmology 2017;124:S57–S65
  11. Renard JP, Fénolland JR, Giraud JM. Glaucoma progression analysis by spectral-domain optical coherence tomography (SD-OCT). J Fr Ophtalmol 2019;42:499–516
  12. Diniz-Filho A, Abe RY, Zangwill LM, Gracitelli CP, Weinreb RN, Girkin CA, et al. Association between intraocular pressure and rates of retinal nerve fiber layer loss measured by optical coherence tomography. Ophthalmology 2016;123:2058–65
  13. Vidas S, Popović-Suić S, Novak Lauš K, Jandroković S, Tomić M, Jukić T, et al. Analysis of ganglion cell complex and retinal nerve fiber layer thickness in glaucoma diagnosis. Acta Clin Croat 2017;56:382–90
  14. Lulli M, Witort E, Papucci L, Torre E, Schipani C, Bergamini C, et al. Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from a